ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ARDS Aridis Pharmaceuticals Inc

0.289
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aridis Pharmaceuticals Inc ARDS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.289 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.289
more quote information »

Recent News

Date Time Source Heading
14/2/202412:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/1/202422:05EDGAR2Form 8-K - Current report
16/12/202308:15GLOBEAridis Pharmaceuticals Announces Adjournment of Annual..
04/11/202308:00EDGAR2Form 8-K - Current report
04/11/202307:15GLOBEAridis Pharmaceuticals Announces Third Quarter 2023..
03/11/202321:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202311:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/9/202306:15EDGAR2Form 8-K - Current report
26/8/202306:05EDGAR2Form 8-K - Current report
05/8/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202306:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202322:17GLOBEAridis Pharmaceuticals Announces $2 Million Offering
02/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
21/7/202320:49EDGAR2Form S-1/A - General form for registration of securities..
21/7/202307:18EDGAR2Form 8-K - Current report
18/7/202306:05GLOBEAridis Receives Agreement from the European Medicines Agency..
18/7/202305:01EDGAR2Form S-1/A - General form for registration of securities..
17/7/202321:36EDGAR2Form S-1/A - General form for registration of securities..
12/7/202322:00GLOBEAridis’ AR-301 Monoclonal Antibody is Among the First..
20/6/202322:00GLOBEAridis Pharmaceuticals' AR-301 Eligible for Consideration..
09/6/202306:05GLOBEAridis Pharmaceuticals Announces First Quarter 2023..
31/5/202322:00GLOBEAridis Receives Agreement from the FDA on a Single..
26/5/202306:05GLOBEAridis Pharmaceuticals Receives Nasdaq Notice on Late Filing..
27/4/202302:15GLOBEAridis Pharmaceuticals Receives Nasdaq Notice on Late Filing..

Your Recent History

Delayed Upgrade Clock